Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical Cancer

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing